Warning: file_get_contents(/home/www/settings/mirror_forum_db_enable_sql): failed to open stream: No such file or directory in /var/www/html/content/Forum/functions.php on line 8
In a statement published Monday on its website, Burisma Holdings announced Hunter Biden would join its board of directors and head the company's legal unit.
"As a new member of the board, I believe that my assistance in consulting the company on matters of transparency, corporate governance and responsibility, international expansion and other priorities will contribute to the economy and benefit the people of Ukraine," Hunter Biden said in the statement.
Burisma owns several Ukrainian oil and gas companies, including Esko Pivnich and Pari, Lenta.ru reported Tuesday. The company also has assets in Ukraine's Dnepr-Donetsk, the Carpathian and the Azov-Kuvan basins.
Burisma produced 11,600 barrels of oil equivalent, or boe, in 2013 and was planning to increase its production in Ukraine by 35-40 percent in 2014, U.S. financier and member of the board of directors Devon Archer told newspaper Capital in late April.
Hunter's father, as U.S. Vice President, has repeatedly rebuked Russia for its reported involvement in Ukraine and has pledged to support efforts to reduce its dependency on Russian energy.
Question: “In the American media you are often linked to the immediate circle of the U.S. Secretary of State Mr. John Kerry and the Vice-president of the United States Mr. Joe Biden.”
Archer: “American journalists really think so (smiles). I do know them.”
(...) A few hours later, the roof collapsed onto the building, and Khanam was trapped under a machine for 12 hours.
“When I was crushed, I was terrified,” she said. “I didn’t think I was going to live anymore.”
The petite 20-year-old began working in the garment industry when she was 14. Seven days a week, 120 hours a week and for $125 per month, Khanam sewed loops onto pants – the loops many of us likely pull our belts through every day.
Khanam now has a head injury, a chest injury and hip injury. Once the breadwinner in her family, she can no longer work.
“If my mom didn’t work, then we wouldn’t be able to get by at all,” she explained. “My brothers and sisters can’t go to school anymore. We can’t buy as much food as we used to.”
More than 1,200 people died and more than 2,500 were injured in the collapse. (...)
Now this is the type of thing that needs to be addressed in healthcare reform. As long as healthcare cost are astronomical, it doesn't even matter who is covered by what, the premiums or bill for subsidies are going to always be outrageous.
Medicine is expensive, sure, but have you ever asked yourself why? The pharmaceutical industry will have you believe that without high prices, we don't get new drugs. The reality is, with high prices we don't always get new drugs we need either. If a new drug is developed and nobody can afford it, where is the benefit from it?
Limiting access to the products of pharmaceutical innovation is nothing new to me. I've seen it for the last 15 years as a doctor with Medecins Sans Frontieres. In one of my first field missions in Uganda, I watched young children with malaria die because the best treatment to give them - artemisinin - was not available and I was forced to use less effective drugs. It was tragic to witness.
I was outraged at remarks made in December, but widely reported only in late January, by the CEO of German pharmaceutical company Bayer, on one of the company's cancer drugs. CEO Marijn Dekkers said that Bayer "didn't develop this product for the Indian market; we developed it for Western patients who could afford it." I was shocked at his candour: Dekkers' comments sum up everything that is wrong with the pharmaceutical research and development (R&D) industry today.
As it currently stands, patents create long monopolies, which allow pharmaceutical companies to charge the maximum price they can without fear of competition. Patients and health providers are put in a near-impossible predicament: Either they pay the market rate, or they wait until the maximum profits have been squeezed out of a drug and its patent expires. Waiting in many cases means dying.
The current system also means some drugs just don't get developed at all; there are some diseases for which there have been no new drugs developed for half a century or more. It's because - while the need is there - these drugs just aren't profitable for the pharmaceutical companies to do research on them. (...)
fyt: Fixed Your Typo. I got that you were attacking the messenger by making the type green, but fyt (to me) means you've creatively edited the post to add some wry humor. I couldn't find any edits. That is all.
fyt: Fixed Your Typo. I got that you were attacking the messenger by making the type green, but fyt (to me) means you've creatively edited the post to add some wry humor. I couldn't find any edits. That is all.
fyt: Fixed Your Typo. I got that you were attacking the messenger by making the type green, but fyt (to me) means you've creatively edited the post to add some wry humor. I couldn't find any edits. That is all.
seems to be endless / relentless cutting and pasting with little or no comment, not unlike another who did much the same. Maybe more diverse in subject matter and with respectful font, but endless.
and this thread seemed to present the opportunity to point out an irony. Business as usual indeed. Much of it pointless.
Maybe I should have responded with this, but it would be shot down as a rightwing political reaction, and then it could be interpreted as if I was defending the program in his post that he was illustrating. Which would not be the case.
When all one does is cut and paste, it has to be assumed at some point the poster believes in and agrees with what they are pasting. And that is because there is no accompanying comments, almost exclusively. So I will put up my c / p response to his c / p. But remember, I am not defending the program, I have to assume he is attacking, because he says nothing.
...as well. Also.
apparently doesn't understand the concept of 